rs2229562
Variant names: 
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_002609.4(PDGFRB):c.*73A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.408 in 1,407,234 control chromosomes in the GnomAD database, including 121,062 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.39   (  12297   hom.,  cov: 32) 
 Exomes 𝑓:  0.41   (  108765   hom.  ) 
Consequence
 PDGFRB
NM_002609.4 3_prime_UTR
NM_002609.4 3_prime_UTR
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.408  
Publications
17 publications found 
Genes affected
 PDGFRB  (HGNC:8804):  (platelet derived growth factor receptor beta) The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017] 
PDGFRB Gene-Disease associations (from GenCC):
- acroosteolysis-keloid-like lesions-premature aging syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- myofibromatosis, infantile, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- basal ganglia calcification, idiopathic, 4Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- bilateral striopallidodentate calcinosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile myofibromatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary progressive mucinous histiocytosisInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67). 
BP6
Variant 5-150115690-T-C is Benign according to our data. Variant chr5-150115690-T-C is described in ClinVar as Benign. ClinVar VariationId is 1221159.Status of the report is criteria_provided_single_submitter, 1 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.429  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PDGFRB | NM_002609.4 | c.*73A>G | 3_prime_UTR_variant | Exon 23 of 23 | ENST00000261799.9 | NP_002600.1 | ||
| PDGFRB | NM_001355016.2 | c.*73A>G | 3_prime_UTR_variant | Exon 22 of 22 | NP_001341945.1 | |||
| PDGFRB | NM_001355017.2 | c.*73A>G | 3_prime_UTR_variant | Exon 23 of 23 | NP_001341946.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.394  AC: 59905AN: 151914Hom.:  12274  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
59905
AN: 
151914
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.410  AC: 514094AN: 1255202Hom.:  108765  Cov.: 18 AF XY:  0.407  AC XY: 250524AN XY: 615562 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
514094
AN: 
1255202
Hom.: 
Cov.: 
18
 AF XY: 
AC XY: 
250524
AN XY: 
615562
show subpopulations 
African (AFR) 
 AF: 
AC: 
11329
AN: 
27296
American (AMR) 
 AF: 
AC: 
6715
AN: 
25898
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
8538
AN: 
18716
East Asian (EAS) 
 AF: 
AC: 
3980
AN: 
36428
South Asian (SAS) 
 AF: 
AC: 
20261
AN: 
63326
European-Finnish (FIN) 
 AF: 
AC: 
10005
AN: 
40274
Middle Eastern (MID) 
 AF: 
AC: 
1585
AN: 
3512
European-Non Finnish (NFE) 
 AF: 
AC: 
430686
AN: 
987544
Other (OTH) 
 AF: 
AC: 
20995
AN: 
52208
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.497 
Heterozygous variant carriers
 0 
 13988 
 27976 
 41964 
 55952 
 69940 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 13294 
 26588 
 39882 
 53176 
 66470 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.394  AC: 59971AN: 152032Hom.:  12297  Cov.: 32 AF XY:  0.382  AC XY: 28400AN XY: 74326 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
59971
AN: 
152032
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
28400
AN XY: 
74326
show subpopulations 
African (AFR) 
 AF: 
AC: 
17527
AN: 
41442
American (AMR) 
 AF: 
AC: 
5406
AN: 
15286
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1604
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
569
AN: 
5154
South Asian (SAS) 
 AF: 
AC: 
1569
AN: 
4814
European-Finnish (FIN) 
 AF: 
AC: 
2485
AN: 
10604
Middle Eastern (MID) 
 AF: 
AC: 
140
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
29467
AN: 
67952
Other (OTH) 
 AF: 
AC: 
856
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.506 
Heterozygous variant carriers
 0 
 1895 
 3790 
 5686 
 7581 
 9476 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 570 
 1140 
 1710 
 2280 
 2850 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
773
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.